Cargando…
In vivo biodistribution, biocompatibility, and efficacy of sorafenib-loaded lipid-based nanosuspensions evaluated experimentally in cancer
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. In this study, sorafenib-loaded lipid-based nanosuspensions (sorafenib-LNS) were first developed as an intravenous injectable formulation to increase the efficacy of sorafenib against HCC. LNS were used as nanocarri...
Autores principales: | Yang, Shaomei, Zhang, Bo, Gong, Xiaowei, Wang, Tianqi, Liu, Yongjun, Zhang, Na |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887074/ https://www.ncbi.nlm.nih.gov/pubmed/27307733 http://dx.doi.org/10.2147/IJN.S104119 |
Ejemplares similares
-
Functionalized docetaxel-loaded lipid-based-nanosuspensions to enhance antitumor efficacy in vivo
por: Pang, Xiuping, et al.
Publicado: (2019) -
Ceramide lipid-based nanosuspension for enhanced delivery of docetaxel with synergistic antitumor efficiency
por: Wang, Tianqi, et al.
Publicado: (2017) -
Preclinical studies of N(3)-O-toluyl-fluorouracil-loaded lipid-based nanosuspensions in H(22)-bearing mice
por: Zhang, Juan, et al.
Publicado: (2014) -
In vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug delivery
por: Woods, A., et al.
Publicado: (2015) -
Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy
por: Wang, Lili, et al.
Publicado: (2012)